Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...

The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...

A new study published in the journal of BMC Nephrology showed that the effectiveness of roxadustat is comparable at varying ...

The Burlington man set out in 2007 to donate blood as frequently as he could in 100 different cities and towns across Massachusetts. The project took 17 years because donors are required to wait 56 ...

Do you feel bloated, fatigued or have frequent digestive discomfort? Small Intestinal Bacterial Overgrowth (SIBO) affects a ...

Following a phase 1b trial, the potent and selective dual inhibitor of IRAK1 and IRAK4 received fast track designation for the treatment of patients with lower-risk myelodysplastic syndrome.

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has ...

Kentucky medical cannabis practitioners could begin writing certifications for medical cannabis treatment on Dec. 1. Local ...

Crohn’s disease may be a lifelong condition, but today, there are an abundance of effective treatments that can help bring ...

Your resting heart rate can tell a lot about your health particularly your cardiovascular health Here’s how it changes with ...

The world of health devices and therapy is evolving faster than ever and 2024 is shaping up to be a groundbreaking year From wearable tech that monitors your vitals in real time to cutting-edge therap ...